SARO SARKISIAN M.D. NPI 1164735387

NPI Information

  • NPI: 1164735387
  • Provider Name: SARO SARKISIAN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1562 OPOSSUMTOWN PIKE
    FREDERICK, MD
    ZIP 21702
  • Phone: (301) 662-8477

Map and Directions

Get Directions

NPI Details

Saro Sarkisian, M.D. is a hematology and oncology internal medicine in Frederick, MD with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Saro Sarkisian, M.D. NPI is 1164735387. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1562 OPOSSUMTOWN PIKE
FREDERICK, MD
ZIP 21702-920
Phone: (301) 662-8477

The NPI 1164735387 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, vedolizumab, 1 mg (HCPCS:J3380)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Transfusion of blood or blood products (HCPCS:36430)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Red blood cells, leukocytes reduced, each unit (HCPCS:P9016)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 7/16/2010 and was last updated on 7/21/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyD0090258MARYLANDYes
2208M00000XHospitalistMD449103PENNSYLVANIANo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.